Search results for "BNP"

showing 10 items of 23 documents

Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive r…

2011

Background— Diastolic dysfunction associated with high blood pressure (BP) leads to cardiac remodeling and fibrosis and progression to congestive heart failure. B-type natriuretic peptide (BNP) has BP-lowering, antifibrotic, and antihypertrophic properties, which makes BNP an attractive agent for attenuating the adverse cardiac remodeling associated with hypertension. In the current study, we tested the effects of sustained cardiac proBNP gene delivery on BP, cardiac function, and remodeling in spontaneously hypertensive rats (SHR). Methods and Results— We used the myocardium-tropic adeno-associated virus serotype 9 (AAV9) vector to achieve continuously enhanced cardiac rat proBNP expressi…

Cardiac function curvemedicine.medical_specialtymedicine.drug_classBNP; Natyriuretic peptides; hypertensive heart diseaseDiastolePhysiology (medical)Internal medicinemedicineNatriuretic peptideNatyriuretic peptidescardiovascular diseasesVentricular remodelingEjection fractionbusiness.industryheart failure natriuretic peptide hypertension.medicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareHypertensive heart diseaseBlood pressureEndocrinologyHeart failurecardiovascular systemCardiologyCardiology and Cardiovascular Medicinebusinesshypertensive heart diseasehormones hormone substitutes and hormone antagonistsBNP
researchProduct

NT-pro-BNP nozīme agrīnā HSM diagnostikā 2. tipa cukura diabēta pacientiem

2020

Ievads. Pacientiem ar otrā tipa cukura diabētu ir ievērojami lielāks risks attīstīties kardiovaskulārai slimībai. Lielai daļai pacientu ar otrā tipa diabētu var attīstīties kardiovaksulāra saslimšana bez tipiskas klīniskās ainas, kā rezultātā kardiovaskulāru slimību diagnosticē novēloti, kad tā jau ir progresējusi. Līdz ar to būtu svarīgi šiem pacientiem veikt skrīningu, lai priekšlaicīgi diagnosticētu vai novērstu kardiovaskulāru slimību attīstību – noteikt NT-pro-BNP. Pētījuma mērķis. Pētīt NT-pro-BNP izmaiņas otrā tipa cukura diabēta pacientiem, kuriem slimības vēsturē nav kardiovaskulāru saslimšanu, un vai NT-pro-BNP līmenim asinīs ir saistība pacienta dzimumu, vecumu un slimošanas ar o…

Cukura diabētsSirds mazspējaKardiovaskulārsMedicīnaNT-pro-BNP
researchProduct

Influencia de la diabetes experimental sobre los mecanismos implicados en la respuesta de las arterias carótida y renal de conejo al péptido natriuré…

2016

La diabetes constituye un importante factor de riesgo de la enfermedad cardiovascular, con una mayor prevalencia de ictus y nefropatía. El péptido natriurético tipo B (BNP) juega un papel importante en la fisiopatología cardiovascular y podría tener acciones protectoras cardiovasculares y nefrovasculares en pacientes diabéticos. En este trabajo hemos estudiado las modificaciones producidas por la diabetes en los mecanismos que regulan la respuesta de las arterias carótida y renal de conejo al BNP. La concentración plasmática de NT-proBNP en conejos diabéticos fue mayor que en conejos control. ARTERIA CARÓTIDA. El BNP indujo una relajación de la arteria carótida, que fue menor en conejo diab…

Diabetes:CIENCIAS MÉDICAS [UNESCO]canales de potasioIctusarteria carótidaUNESCO::CIENCIAS MÉDICAScardiovascular systemarteria renalprostanoidescardiovascular diseasesóxido nítricoendoteliohuman activitieshormones hormone substitutes and hormone antagonistsnefropatíaBNP
researchProduct

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP).

2012

Abstract B-type natriuretic peptide (BNP) is a member of a four-natriuretic peptide family that shares a common 17-peptide ring structure. The N-terminal fragment (NT-pro-BNP) is biologically inert, but both are secreted in the plasma in equimolar quantities and both have been evaluated for use in the management of congestive heart failure. BNP and NT-pro-BNP are frequently used in the diagnosis of congestive heart failure and distinguishing between patients with dyspnoea of cardiac or pulmonary origin. Values of NT-pro-BNP are affected by age or the presence of one or several co-morbidities such as chronic renal failure, type 2 diabetes, and acute coronary syndrome. ‘Normal’ values of thes…

Heart FailureAge FactorsReproducibility of ResultsComorbidityReview ArticlePrognosisSeverity of Illness IndexPeptide FragmentsDiagnosis DifferentialDyspneaPredictive Value of TestsRisk FactorsNatriuretic Peptide BrainHumansnatriuretic peptidesprognostic valueshormones hormone substitutes and hormone antagonistsBiomarkersNT-pro-BNPCardiovascular journal of Africa
researchProduct

Are BNP plasma levels useful in heart failure diagnosis each time? A dyspneic patient with anasarca.

2011

Heart FailureMalemedicine.medical_specialtyEdema Cardiacbusiness.industryBNP Heart FailureGeneral MedicinePlasma levelsMiddle Agedmedicine.diseaseAnasarcaDiagnosis DifferentialDyspneaHeart failureInternal medicineNatriuretic Peptide BrainEmergency MedicinemedicineCardiologyHumansmedicine.symptombusinessBiomarkersThe American journal of emergency medicine
researchProduct

Immune-inflammatory and metabolic effects of high dose furosemide plus hypertonic saline solution (HSS) treatment in cirrhotic subjects with refracto…

2016

Introduction Patients with chronic liver diseases are usually thin as a result of hypermetabolism and malnutrition expressed by reduced levels of leptin and impairment of other adyponectins such as visfatin. Aims We evaluated the metabolic and inflammatory effects of intravenous high-dose furosemide plus hypertonic saline solutions (HSS) compared with repeated paracentesis and a standard oral diuretic schedule, in patients with cirrhosis and refractory ascites. Methods 59 consecutive cirrhotic patients with refractory ascites unresponsive to outpatient treatment. Enrolled subjects were randomized to treatment with intravenous infusion of furosemide (125-250mg⁄bid) plus small volumes of HSS …

Liver CirrhosisMaleLeptinCirrhosisPhysiologyPeptide Hormonesmedicine.medical_treatmentdiureticlcsh:MedicineVisfatinPathology and Laboratory MedicineFurosemide; Hypertonic Saline Solution; TNF-alpha; IL-1beta; IL-6; ANP; BNP; Visfatin; Leptin; cirrhosis; refractory ascites; paracentesis; diureticBiochemistryGastroenterology0302 clinical medicineRecurrenceFurosemideImmune PhysiologyMedicine and Health SciencesParacentesisDiureticslcsh:ScienceImmune ResponseSalineHypertonicInnate Immune SystemMultidisciplinarymedicine.diagnostic_testLiver DiseasesPhysicsLeptinrefractory asciteAscitesClassical MechanicsFurosemideHematologyMiddle AgedBody FluidsBloodTreatment OutcomeCirrhosis030220 oncology & carcinogenesisPhysical SciencesHypermetabolismCytokinesAdministration IntravenousFemale030211 gastroenterology & hepatologyAnatomyInflammation MediatorsANPResearch ArticleTNF-alphamedicine.drugparacentesimedicine.medical_specialtyInflammatory DiseasesImmunologyGastroenterology and HepatologyBlood Plasma03 medical and health sciencesSigns and SymptomsDiagnostic MedicineOsmotic PressureInternal medicinePressuremedicineTonicityHumansAgedInflammationSaline Solution HypertonicIL-6business.industrylcsh:RBiology and Life SciencesMolecular DevelopmentIL-1betamedicine.diseaseHormonesHypertonic salineEndocrinologyImmune Systemlcsh:QHypertonic Saline SolutionDiureticbusinessBiomarkersDevelopmental BiologyBNPcirrhosi
researchProduct

Cardiac risk stratification in elective non-cardiac surgery: Role of NT-proBNP

2011

AIM: The aim of the study was to investigate the utility of NT-proBNP measurement for the stratification of presurgical cardiac risk. METHODS: Cardiac risk before elective non-cardiac surgery was evaluated in 82 consecutive patients. From each patient a venous blood sample was drawn to determinate NT-proBNP levels. Patients were followed up over three months in order to detect the occurrence of cardiac adverse events. RESULTS: NT-proBNP was positively correlated (P<0.0001) with age, days of hospitalization (P=0.001) and ASA class (P=0.001). High surgical risk (P<0.0001), diabetes (P=0.004), dyslipidemia (P=0.006) and elevated levels of NT-proBNP (P<0.0001) were significantly correlated with…

MaleChi-Square DistributionTime FactorsMiddle AgedRisk AssessmentPeptide FragmentsUp-RegulationLogistic ModelsTreatment OutcomeItalyNT-proBNPCardiovascular DiseasesElective Surgical ProceduresPredictive Value of TestsRisk FactorsSurgical Procedures OperativeNatriuretic Peptide BrainPreoperative PeriodOdds RatioHumansFemaleBiomarkersAged
researchProduct

Natriuretic peptide system expression in murine and human submandibular salivary glands: a study of the spatial localisation of ANB, BNP, CNP and the…

2019

AbstractThe natriuretic peptide (NP) system comprises of three ligands, the Atrial Natriuretic Peptide (ANP), Brain Natriuretic peptide (BNP) and C-type Natriuretic peptide (CNP), and three natriuretic peptide receptors, NPRA, NPRB and NPRC. Here we present a comprehensive study of the natriuretic peptide system in healthy murine and human submandibular salivary glands (SMGs). We show CNP is the dominant NP in mouse and human SMG and is expressed together with NP receptors in ducts, autonomic nerves and the microvasculature of the gland, suggesting CNP autocrine signalling may take place in some of these glandular structures. These data suggest the NP system may control salivary gland funct…

MaleSettore BIO/17 - Istologia0301 basic medicinemedicine.medical_specialtyHistologyReceptors PeptidePhysiologymedicine.drug_classAtrial natriuretic peptide ANPNatriuretic peptide receptor B NPRBMice03 medical and health sciences0302 clinical medicineAtrial natriuretic peptideInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideAnimalsHumansAutonomic nervous systemB-type natriuretic peptide BNPNatriuretic peptide receptor C NPRCAutocrine signallingReceptorSalivary glandSubmandibular glandSalivary glandC-type natriuretic peptide CNPChemistryNatriuretic Peptide C-TypeCell BiologyGeneral MedicineNatriuretic peptide receptor A NPRABrain natriuretic peptideSubmandibular glandNeoplasm Proteins030104 developmental biologymedicine.anatomical_structureEndocrinologyOral squamous cell carcinoma030220 oncology & carcinogenesisCarcinoma Squamous CellFemaleMouth NeoplasmsAtrial Natriuretic FactorHomeostasisJournal of Molecular Histology
researchProduct

Short term prognostic role of NT-proBNP in patients after myocardial infarction

2009

Aim. The clinical and prognostic role of cardiac natriuretic peptides (CNP) in patients with heart failure is well known; recently, several studies have evaluated the possibility of using CNP to evaluate their potential prognostic role in patients with acute coronary syndromes (ACS). The aim of this study was to evaluate the short term prognostic value of NT-proBNP in 70 patients admitted for ACS. Methods. The authors studied 70 patients with ACS, evaluating, at admission, clinical-anamnestic, instrumental and laboratory characteristics including NT-proBNP plasma levels. Patients were monitored in a 6-month-follow-up to record adverse fatal events and their possible correlation with baselin…

MaleTime FactorsMyocardial InfarctionMiddle AgedPrognosisSettore MED/11 - Malattie Dell'Apparato CardiovascolareNT-proBNP myocardial infarctionPeptide FragmentsLogistic ModelsPredictive Value of TestsRisk FactorsNT-proBNPNatriuretic Peptide BrainHumansFemaleBiomarkersAgedFollow-Up StudiesRetrospective Studies
researchProduct

Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP

2012

ObjectivesThis study sought to investigate plasma levels of circulating cardiac natriuretic peptides, atrial natriuretic peptide (ANP) and B-type or brain natriuretic peptide (BNP), in the general community, focusing on their relative differences in worsening human hypertension.BackgroundAlthough ANP and BNP are well-characterized regulators of blood pressure in humans, little is known at the population level about their relationship with hypertension. The authors hypothesized that hypertension is associated with a lack of activation of these hormones or their molecular precursors.MethodsThe study cohort (N = 2,082, age >45 years) was derived from a random sample from Rochester, Minnesota, …

Malemedicine.medical_specialtySettore MED/09 - Medicina Internahypertensionmedicine.drug_class030204 cardiovascular system & hematologyCardiac hormonesArticle03 medical and health sciences0302 clinical medicineAtrial natriuretic peptideInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumanscardiovascular diseasesBNP; ANP; Human HypertensionAged030304 developmental biology0303 health sciencesnatriuretic peptideExtramuralbusiness.industryPlasma levelsMiddle AgedBrain natriuretic peptideSettore MED/11 - Malattie Dell'Apparato CardiovascolareproBNPEndocrinologyNT-proBNPHuman HypertensionLinear Modelscardiovascular systemFemaleCardiology and Cardiovascular MedicinebusinessAtrial Natriuretic Factorhormones hormone substitutes and hormone antagonistsANPcirculatory and respiratory physiologyBNPJournal of the American College of Cardiology
researchProduct